Summary
MicroInstrmntsBP aims at planning the best business approach to the commercialization of micro-surgical instruments with the same dexterity of state-of-the-art instruments but smaller in size. The reduction in size allows the instruments to be introduced and used in smaller surgical fields and will open up robotic micro-surgery and endoscopic applications, that are currently beyond the capabilities of state-of-the-art products and have an estimated market size 10x the current 2014 market size for wristed surgical instruments (0.5 Billion USD).
Micro-wristed instruments are enabled by a proprietary, integrated design and a proprietary manufacturing process. Medra's design & manufacturing process for 3d micro parts allows parts to mate together with high precision. Current manufacturing technologies are limited in the fabrication of small 3d parts, especially parts for assemblies, by limits on the achievable geometry of the parts and their tolerances. We have overcome such limitations and are able produce very precise small parts in very hard and high yield strength materials. Such an approach allows to counter the weakening of the parts due to the scaling down of the dimensions. 5 month out goals are international IP filings and definition of first viable product based on surgical procedure-specific market size and risk-adjusted business opportunity.
Micro-wristed instruments are enabled by a proprietary, integrated design and a proprietary manufacturing process. Medra's design & manufacturing process for 3d micro parts allows parts to mate together with high precision. Current manufacturing technologies are limited in the fabrication of small 3d parts, especially parts for assemblies, by limits on the achievable geometry of the parts and their tolerances. We have overcome such limitations and are able produce very precise small parts in very hard and high yield strength materials. Such an approach allows to counter the weakening of the parts due to the scaling down of the dimensions. 5 month out goals are international IP filings and definition of first viable product based on surgical procedure-specific market size and risk-adjusted business opportunity.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/663776 |
| Start date: | 01-01-2015 |
| End date: | 31-05-2015 |
| Total budget - Public funding: | 71 429,00 Euro - 50 000,00 Euro |
Cordis data
Original description
MicroInstrmntsBP aims at planning the best business approach to the commercialization of micro-surgical instruments with the same dexterity of state-of-the-art instruments but smaller in size. The reduction in size allows the instruments to be introduced and used in smaller surgical fields and will open up robotic micro-surgery and endoscopic applications, that are currently beyond the capabilities of state-of-the-art products and have an estimated market size 10x the current 2014 market size for wristed surgical instruments (0.5 Billion USD).Micro-wristed instruments are enabled by a proprietary, integrated design and a proprietary manufacturing process. Medra's design & manufacturing process for 3d micro parts allows parts to mate together with high precision. Current manufacturing technologies are limited in the fabrication of small 3d parts, especially parts for assemblies, by limits on the achievable geometry of the parts and their tolerances. We have overcome such limitations and are able produce very precise small parts in very hard and high yield strength materials. Such an approach allows to counter the weakening of the parts due to the scaling down of the dimensions. 5 month out goals are international IP filings and definition of first viable product based on surgical procedure-specific market size and risk-adjusted business opportunity.
Status
CLOSEDCall topic
NMP-25-2014-1Update Date
27-10-2022
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
H2020-EU.2.1.2. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies
